Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the ...

Swarm was formed in 2022 and has now emerged with Martin Olin – previously chief executive of BerGenBio and Symphogen – at ...

Swarm was formed in 2022 and has now emerged with Martin Olin – previously chief executive of BerGenBio and Symphogen – at ...

Despite making up a sizable chunk of entry-level employees at the biggest U.S. biopharmas, the share of east Asian Americans drops dramatically as you move up the ranks. | Despite making up a sizable ...

Reliever Tanner Scott’s $72 million, four-year contract with the Los Angeles Dodgers includes $21 million in deferred ...

MicroAlgae Solutions India Pvt Ltd is not merely a company; it is a vital force in the quest for ecological balance and ...

If the 118th Congress does not reauthorize the farm bill, it will be incumbent upon the 119 th Congress to pass an updated ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Chris Viehbacher spoke out about the uncertain policy environment for life sciences companies, though he didn't single ...

Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

The work explores the potential of wood waste as an innovative, eco-friendly solution to a growing environmental challenge. This research has the power to not only protect sensitive electronics but al ...